Document is current
Any future updates will be listed below
-
Authors
Moore, Madelyn N. https://orcid.org/0000-0001-8008-5275
Person, Kelsey L. https://orcid.org/0000-0002-7324-8301
Robleto, Valeria L. https://orcid.org/0000-0002-1798-753X
Alwin, Abigail R. https://orcid.org/0009-0007-0846-0668
Krusemark, Campbell L. https://orcid.org/0009-0009-0008-8122
Foster, Noah
Ray, Caroline
Inoue, Asuka https://orcid.org/0000-0003-0805-4049
Jackson, Michael R.
Sheedlo, Michael J.
Barak, Lawrence S.
Marron Fernandez de Velasco, Ezequiel
Olson, Steven H.
Slosky, Lauren M. https://orcid.org/0000-0002-9471-9117
- License Information
-
More Information
Article History
Received: 17 November 2024
Accepted: 17 September 2025
First Online: 22 October 2025
Competing interests
: US Patent 9,868,707 relating to composition of matter for SBI-553 and its derivatives was issued to the Sanford Burnham Prebys Medical Discovery Institute (SBP) and Duke University, and US Patent 10,118,902 has been issued to SBP. Patent application US20240398806 related to the use of SBI-553 and its derivatives has been filed by Duke University. L.M.S., S.H.O. and M.R.J. are scientific founders of BAM Therapeutics and hold a financial interest in the company. The remaining authors declare no competing interests.
